Doruk Erkan

21PUBLICATIONS
54CO-AUTHORS
Clinical chemistry (incl. diagnostics)Respiratory diseasesRheumatology and arthritisAutoimmunityOther education not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 07, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions.

Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah

|Feb 03, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository.

Yasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade

|Aug 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis.

Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo

|May 03, 2024
Rethinking antiphospholipid syndrome to guide future management and research.

Jason S Knight, Doruk Erkan

|Feb 27, 2024
Persistent Moderate-to-High Levels of Isolated Anticardiolipin Antibody IgA or Anti-β2-Glycoprotein-I IgA Isotypes: Do They Have Any Clinical Relevance?

Ayse Bahar Keleşoğlu Dinçer, Jonathan Thaler, Doruk Erkan

|Feb 25, 2024
Reply.

Medha Barbhaiya, Stephane Zuily, Guilherme de Jesus

Pageof 4

Frequent Collaborators

8 joint publications

Medha Barbhaiya

8 joint publications

Maria Tektonidou

7 joint publications

Michelle Petri

7 joint publications

Savino Sciascia